CMRA
Healthcare BiotechnologyComera Life Sciences Holdings, Inc.
$0.00
+0.00 +0.00% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 11:42 AM ET | 0.00 |
Key Stats
Market Cap
3,073.78
Avg Volume
490
EPS
-$0.11
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
-0.00
P/S Ratio
0.00
EV/EBITDA
-0.41
EV/Revenue
3.12
Margins
Gross Margin 73.5%
Operating Margin (1582.5%)
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Revenue Growth (YoY)
(42.0%)
Return on Equity
(1629.0%)
Return on Assets
(119.3%)
Liquidity & Leverage
Current Ratio
0.90
Quick Ratio
0.64
Debt / Equity
5.49
Total Cash
1.77M
Total Debt
561,468
About
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
comeralifesciences.com